These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8419476)

  • 41. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
    Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
    Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of Ag-presenting cells in the conjunctiva during the development of experimental immune-mediated blepharoconjunctivitis.
    Ozaki A; Fukushima A; Ishida W; Zinchuk O; Fukata K; Hayashi Y; Enzan H; Takata M; Yagita H; Ueno H
    Curr Eye Res; 2004; 29(4-5):277-86. PubMed ID: 15590473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation.
    Harding CV; Collins DS; Kanagawa O; Unanue ER
    J Immunol; 1991 Nov; 147(9):2860-3. PubMed ID: 1918996
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice.
    Serreze DV; Gaskins HR; Leiter EH
    J Immunol; 1993 Mar; 150(6):2534-43. PubMed ID: 8450229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
    Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumor-specific cytolytic T lymphocytes.
    Yeh KY; McAdam AJ; Pulaski BA; Shastri N; Frelinger JG; Lord EM
    J Immunol; 1998 Jun; 160(12):5773-80. PubMed ID: 9637487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.
    Rodriguez A; Regnault A; Kleijmeer M; Ricciardi-Castagnoli P; Amigorena S
    Nat Cell Biol; 1999 Oct; 1(6):362-8. PubMed ID: 10559964
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficient presentation of multivalent antigens targeted to various cell surface molecules of dendritic cells and surface Ig of antigen-specific B cells.
    Serre K; Machy P; Grivel JC; Jolly G; Brun N; Barbet J; Leserman L
    J Immunol; 1998 Dec; 161(11):6059-67. PubMed ID: 9834089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterogeneous populations of class II MHC+ cells in human dermal cell suspensions. Identification of a small subset responsible for potent dermal antigen-presenting cell activity with features analogous to Langerhans cells.
    Meunier L; Gonzalez-Ramos A; Cooper KD
    J Immunol; 1993 Oct; 151(8):4067-80. PubMed ID: 8409386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A quantitative analysis of lymphokine release from activated T cells. Evidence for a novel form of T-T collaboration in vitro.
    Gill RG; Lafferty KJ
    J Immunol; 1989 Dec; 143(12):4009-14. PubMed ID: 2512346
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes.
    Prina E; Jouanne C; de Souza Lão S; Szabo A; Guillet JG; Antoine JC
    J Immunol; 1993 Aug; 151(4):2050-61. PubMed ID: 8102156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on the capacity of B cells as well as T cells to serve as accessory cells for the activation of herpes simplex virus-specific cytolytic T cells.
    Grammer SF; Ishioka GY; Chesnut RW
    J Immunol; 1988 Mar; 140(6):2016-22. PubMed ID: 2831277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of lung dendritic cells and B cells in stimulating naive antigen-specific T cells.
    Masten BJ; Lipscomb MF
    J Immunol; 1999 Feb; 162(3):1310-7. PubMed ID: 9973384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Processing and presentation of type II collagen, a fibrillar autoantigen, by H-2q antigen-presenting cells.
    Manoury-Schwartz B; Chiocchia G; Fournier C
    Eur J Immunol; 1995 Dec; 25(12):3235-42. PubMed ID: 8566006
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen.
    Sigal LJ; Crotty S; Andino R; Rock KL
    Nature; 1999 Mar; 398(6722):77-80. PubMed ID: 10078533
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alternative processing for MHC class I presentation by immature and CpG-activated dendritic cells.
    Chen L; Jondal M
    Eur J Immunol; 2004 Apr; 34(4):952-60. PubMed ID: 15048705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diversity in MHC class II ovalbumin T cell epitopes generated by distinct proteases.
    Vidard L; Rock KL; Benacerraf B
    J Immunol; 1992 Jul; 149(2):498-504. PubMed ID: 1378066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancement of B cell function as antigen-presenting cell during interplay with Th cells.
    Nakamachi K; Nagai K; Nariuchi H; Kakiuchi T
    Immunobiology; 1994 Jun; 190(4-5):317-32. PubMed ID: 7982718
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stable association of processed antigen with antigen-presenting cell membranes.
    Jensen PE
    J Immunol; 1989 Jul; 143(2):420-5. PubMed ID: 2786907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selective inhibition of antigen presentation to cloned T cells by protease inhibitors.
    Puri J; Factorovich Y
    J Immunol; 1988 Nov; 141(10):3313-7. PubMed ID: 3263420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.